Compugen (CGEN) Liabilities and Shareholders Equity (2009 - 2026)

Compugen (CGEN) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $145.9 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 26.35% year-over-year to $145.9 million; the trailing twelve-month figure through Mar 2026 stood at $506.8 million (up 9.2% YoY), and the FY2025 full-year result was $156.6 million, up 36.15% from the prior year.
• Liabilities and Shareholders Equity declined to $145.9 million in Q1 2026, from $156.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $156.6 million in Q4 2025 to a low of $67.6 million in Q3 2023.
• A 5-year average of $109.4 million and a median of $110.3 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity plunged 31.96% in 2023 and jumped 82.69% in 2024, its largest moves.
• Tracing CGEN's Liabilities and Shareholders Equity over 5 years: stood at $94.2 million in 2022, then increased by 28.84% to $121.3 million in 2023, then fell by 5.22% to $115.0 million in 2024, then surged by 36.15% to $156.6 million in 2025, then declined by 6.84% to $145.9 million in 2026.
• Business Quant data shows CGEN's Liabilities and Shareholders Equity at $145.9 million in Q1 2026, $156.6 million in Q4 2025, and $97.8 million in Q3 2025.